-
Part 1 | Session 1 CHAMPION-AF: LAA Closure vs OAC in AF Outcomes
-
Part 1 | Session 2 ALERT: Under-treatment in AS and MR
-
Part 1 | Session 3 PRO-TAVI: TAVI With or Without Routine PCI
-
Part 1 | Session 4 Dig-RHD: Digoxin in Rheumatic Heart Disease
-
Part 2 | Session 1 VESALIUS-CV, KARDINAL, CHIP-BCIS3 & More
-
Part 2 | Session 2 CHAMPION-AF, HI-PEITHO, STEMI-DTU
-
Part 3 | Session 1 Door to Unload Randomized Clinical Trial
-
Part 3 | Session 2 ALL-RISE – Coronary Physiology From Angiography vs Pressure Wire for PCI
-
Part 3 | Session 4 The STEMI-DTU Trial – Primary Unloading and Delayed Reperfusion in STEMI
-
Part 3 | Session 6 ACC 2026 with Dr Mehran: Leadership, Vision, and the Future of the College
-
Part 3 | Session 7 Heart Failure in 2026: Practical Therapy Lessons From ACC.26
-
Part 3 | Session 8 RECOVER-Autonomic - Ivabradine for Post-COVID POTS
-
Part 3 | Session 9 ORBITA-CTO - PCI Versus Placebo for Chronic Total Occlusion in Stable Angina
-
Part 3 | Session 10 CHIP-BCIS3 – Percutaneous LV Unloading in High-Risk PCI
-
Part 3 | Session 11 Dr Reddy & Dr Nair on CHAMPION-AF: Redefining Stroke Prevention
-
Part 3 | Session 12 FAST III - FFR vs vFFR to Guide Revascularisation
-
Part 3 | Session 13 AI-Based Retinal Imaging for Atherosclerotic Cardiovascular Risk
-
Part 3 | Session 14 CORALreef — Durability of Enlicitide for Lipid Lowering in Hypercholesterolaemia
-
Part 4 | Session 1 STEMI-DTU, GOFRESH, and HI-PEITHO
-
Part 4 | Session 2 SURPASS CVOT, HI-PEITHO, SURVIV
-
Part 4 | Session 3 Top Takeaways from the 2026 Dyslipidaemia Guidelines
-
Part 4 | Session 4 3 ACC.26 Highlights for the Cardiology Pharmacist
Ahead of ACC.26 in New Orleans, Dr Azeem Latib (Montefiore Medical Center, US) and Prof Nicolas Van Mieghem join us for a rapid-fire preview of the late-breaking clinical trials most likely to reshape interventional and structural cardiology practice.
From pulmonary embolism and left atrial appendage closure to heart failure, STEMI unloading, high-risk PCI, and cerebral protection in TAVI — they cut straight to what the trial designs, endpoints, and safety signals mean for real-world decision-making in the cath lab.
Videographer: Mike Knight
Editor: Mirjam Boros
Support: This is an independent video produced by Radcliffe Cardiology.
Keep up-to-date with our video collection from the American College of Cardiology's 75th Annual Scientific Session, bringing you the latest from late-breaking science, featured research, and clinical horizon sessions.
Catch our congress preview and wrap-up in the NVM Cardiology Meeting Reflections series, alongside concise Expert Interviews with leading faculty distilling the key take-home messages for clinical practice — plus in-depth Highlights breaking down the most impactful trials of the meeting.
More from this programme
Part 1
Late-Breaker Discussions
Part 2
Between the Sessions with Dr Purvi Parwani
Part 3
Expert Interviews
Part 4
Highlights
Part 5
Market Watch
Part 6
NVM Cardiology Meeting Reflections
Faculty Biographies
Azeem Latib
Section Head of Interventional Cardiology
Dr Mohamed Azeem Latib was born and raised in South Africa, where he also completed his early medical training. He later advanced his clinical and professional career internationally. He now resides in New York City, where he serves as the Section Head and Director of Interventional Cardiology and the Director of Structural Heart Interventions at the Montefiore-Einstein Center for Heart & Vascular Care. His career has spanned multiple countries and premier cardiovascular institutions.
Academic History
Dr Latib earned his Bachelor of Medicine, Bachelor of Surgery (MB BCh) from the University of the Witwatersrand in Johannesburg, South Africa, in 1995. He completed a fellowship with the College of Physicians of South Africa in 2002 and received his certificate in cardiology in 2005.
He pursued advanced subspecialty training in Europe, completing a Master’s degree in Interventional Cardiology at the San Raffaele Scientific Institute and University…
Nicolas M Van Mieghem
Full Professor of Interventional Cardiology
Prof Van Mieghem initially intended to train as a cardiac surgeon but decided to specialise in interventional cardiology instead, following advice from a mentor. This decision was cemented when he read the first-in-human case report of transcatheter aortic valve implantation (TAVI) in Circulation by Alain Cribier in 2002. Prof Van Mieghem believes that great cardiologist genuinely cares for their patients. He names Gary Roubin, Dr Manu Malbrain and Professor Patrick Serruys among his mentors.
Academic History
Prof. Nicolas M. Van Mieghem completed his medical training at the Catholic University of Leuven (Belgium), where he earned both his medical degree and his specialist degree in cardiology. During his time in Leuven, he developed a strong interest in cardiovascular medicine, particularly in the emerging field of minimally invasive cardiac interventions. After finishing his core medical and cardiology training, he pursued multiple advanced…
Comments